Roivant Sciences Ownership | Who Owns Roivant Sciences?

Overview Forecast RevenueFinancials Chart Transcripts

Roivant Sciences Ownership Summary

Roivant Sciences is owned by 17.65% institutional investors, 22.79% insiders, and 59.55% retail investors. Fmr is the largest institutional shareholder, holding 11.19% of ROIV shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 4.06% of its assets in Roivant Sciences shares.

ROIV Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Roivant Sciences	17.65%	22.79%	59.55%
Sector	Healthcare Stocks	35.58%	11.87%	52.55%
Industry	Biotech Stocks	35.75%	11.83%	52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Fmr	77.98M	11.19%	$2.16B
Morgan stanley	51.83M	7.44%	$1.44B
Blackrock funding, inc. /de	44.25M	6.35%	$1.23B
Vanguard group	42.06M	6.18%	$912.68M
Sb investment advisers (uk)	40.32M	5.93%	$609.97M
Blackrock	35.37M	4.41%	$373.86M
Qvt financial lp	25.16M	3.61%	$696.97M
Ubs group	22.62M	3.25%	$626.56M
State street	16.19M	2.32%	$448.37M
Adage capital partners gp	12.79M	1.84%	$354.40M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Qvt financial lp	25.16M	51.04%	$696.97M
Atalaya capital management lp	1.71M	40.31%	$18.13M
Patient square capital lp	8.17M	40.13%	$226.20M
Whitefort capital management, lp	1.42M	11.59%	$39.31M
Davern capital partners, lp	873.40K	6.64%	$24.19M
Cutter capital management, lp	1.30M	5.71%	$13.12M
Blackbarn capital partners lp	2.29M	5.09%	$63.30M
Darwin global management	6.80M	4.76%	$179.52M
Adar1 capital management	3.35M	4.76%	$50.65M
Sb investment advisers (uk)	40.32M	4.60%	$609.97M

Top Buyers

Holder	Shares	% Assets	Change
Fmr	77.98M	0.11%	12.20M
Farallon capital management	9.68M	1.53%	9.64M
Darwin global management	6.80M	4.76%	6.80M
Norges bank	5.20M	0.01%	5.20M
Aqr capital management	5.95M	0.07%	5.07M

Top Sellers

Holder	Shares	% Assets	Change
Sb investment advisers (uk)	40.32M	4.60%	-19.64M
Morgan stanley	51.83M	0.09%	-6.53M
Anchorage capital group	-	-	-4.83M
Avoro capital advisors	-	-	-4.65M
Toms capital investment management lp	-	-	-4.09M

New Positions

Holder	Shares	% Assets	Change	Value
Darwin global management	6.80M	4.76%	6.80M	$179.52M
Norges bank	5.20M	0.01%	5.20M	$112.75M
Vanguard fiduciary trust	2.81M	0.02%	2.81M	$77.87M
Maverick capital	1.63M	0.52%	1.63M	$45.07M
Cutter capital management, lp	1.30M	5.71%	1.30M	$13.12M

Sold Out

Holder	Change
Optiver b.v.	-2.00
Stephens consulting	-3.00
Mather group, llc.	-13.00
Cornerstone planning group	-27.00
Riverview trust	-45.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	240	-42.72%	123,029,474	-75.82%	17	0.33%	131	-49.42%	64	-33.33%
Dec 31, 2025	302	-16.80%	336,769,510	-32.86%	49	0.91%	194	1.04%	60	-37.50%
Sep 30, 2025	297	-14.41%	349,519,827	-24.94%	51	1.19%	157	-11.80%	81	-23.58%
Jun 30, 2025	351	8.67%	514,292,667	-7.04%	72	1.24%	180	19.21%	107	0.94%
Mar 31, 2025	15	-95.41%	102,194,746	-81.83%	14	0.23%	6	-96.18%	3	-97.12%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Growth Compy Commingled Pl S	29.08M	4.06%	419.32K
Fidelity Growth Company Fund	22.06M	3.08%	283.00K
Fidelity Growth Compy Commingled Pl O	21.15M	2.86%	439.20K
iShares Core S&P Mid-Cap ETF	15.22M	2.13%	-7.66K
Vanguard Total Stock Mkt Idx Inv	14.83M	2.06%	37.63K
Vanguard US Total Market Shares ETF	14.26M	2.00%	14.26M
Vanguard Small Cap Index	10.72M	1.49%	-20.55K
SPDR® S&P Biotech ETF	7.21M	1.06%	16.07K
Invesco S&P MidCap Quality ETF	6.02M	0.89%	-
Fidelity Growth Company K6	6.14M	0.86%	31.98K

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 22, 2026	Venker Eric	President & Immunovant CEO	Sell	$6.05M
Apr 20, 2026	Venker Eric	President & Immunovant CEO	Sell	$5.92M
Apr 16, 2026	Gline Matthew	CEO	Sell	$8.45M
Apr 08, 2026	Humes Jennifer	Chief Accounting Officer	Sell	$384.07K
Mar 26, 2026	Fitzgerald Meghan	-	Sell	$1.92M

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	4
2026 Q1	-	24
2025 Q4	-	53
2025 Q3	1	9
2025 Q2	-	11

ROIV Ownership FAQ

Who Owns Roivant Sciences?

Roivant Sciences shareholders are primarily institutional investors at 17.65%, followed by 22.79% insiders and 59.56% retail investors. The average institutional ownership in Roivant Sciences's industry, Biotech Stocks , is 35.75%, which Roivant Sciences falls below.

Who owns the most shares of Roivant Sciences?

Roivant Sciences’s largest shareholders are Fmr (77.98M shares, 11.19%), Morgan stanley (51.83M shares, 7.44%), and Blackrock funding, inc. /de (44.25M shares, 6.35%). Together, they hold 24.98% of Roivant Sciences’s total shares outstanding.

Does Blackrock own Roivant Sciences?

Yes, BlackRock owns 4.41% of Roivant Sciences, totaling 35.37M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 373.86M$. In the last quarter, BlackRock decreased its holdings by -817K shares, a -2.26% change.

Who is Roivant Sciences’s biggest shareholder by percentage of total assets invested?

Qvt financial lp is Roivant Sciences’s biggest shareholder by percentage of total assets invested, with 51.04% of its assets in 25.16M Roivant Sciences shares, valued at 696.97M$.

Who is the top mutual fund holder of Roivant Sciences shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of Roivant Sciences shares, with 4.06% of its total shares outstanding invested in 29.08M Roivant Sciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools